Showing results (751-760 of 3,080) with videos related to

Sort By:
Pageof 308
Drug Safety|August 12, 2003
Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significanceGordon S Francis, Yves Grumser, Enrica Alteri, et al.
Drug Safety|June 20, 2003
Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concernsJulianna Lisziewicz, Andrea Foli, Mark Wainberg, et al.
Drug Safety|June 20, 2003
Benefit-risk assessment of treatments for heparin-induced thrombocytopeniaHarry Messmore, Walter Jeske, William Wehrmacher, et al.
Drug Safety|June 20, 2003
Treatment of psychosis in Parkinson's disease: safety considerationsHubert H Fernandez, Martha E Trieschmann, Joseph H Friedman
Drug Safety|March 1, 2003
What can consumer adverse drug reaction reporting add to existing health professional-based systems? Focus on the developing worldRohini B M Fernandopulle, Krisantha Weerasuriya
Drug Safety|October 22, 2010
An algorithm for integrating contraindications into electronic prescribing decision supportRobin E Ferner, Jamie J Coleman
Drug Safety|February 22, 2011
Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBaseJohanna Strandell, Ola Caster, Andrew Bate, et al.
Drug Safety|May 22, 2010
Validation of statistical signal detection procedures in eudravigilance post-authorization data: a retrospective evaluation of the potential for earlier signallingYolanda Alvarez, Ana Hidalgo, Francois Maignen, et al.
Drug Safety|May 22, 2010
Infliximab paediatric Crohn's disease educational plan: a European, cross-sectional, multicentre evaluationAlejandro Arana, Sam Allen, Jörg Burkowitz, et al.
Drug Safety|July 20, 2010
Isotretinoin exposure during pregnancy: assessment of spontaneous reports in FranceElisabeth Autret-Leca, Carmen Kreft-Jais, Elisabeth Elefant, et al.
Pageof 308